Home›Stocks›MLAB

MLAB — structural market context

Mesa Laboratories, Inc. Common

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

MLAB short interest & days to cover

SHARES SHORT
324K
% OF FLOAT
—
DAYS TO COVER
2.5
CHANGE VS PRIOR
+18.2%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-07-31 (18d ago)

MLAB fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-07-08 · 41d91$96.16
2026-07-02 · 47d22$104.39
2026-06-17 · 62d116$99.68

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

MLAB insider buying and selling (Form 4)

Last 12 months, open-market only: 2 purchases · 1 sale · 2 distinct buyers in 30 days

InsiderTypeSharesValueFiled
Sullivan John James · directorSell (S)7K$800K2026-08-17
Kadia Siddhartha · officer: President and CEOBuy (P)7K$800K2026-08-17
Tripeny R Tony · directorBuy (P)900$102K2026-08-17

SEC Form 4 filings, open-market purchases and sales only (codes P and S); grants and option exercises excluded. Attributed public records.

Frequently asked questions

Are insiders buying MLAB?
In the last 12 months of SEC Form 4 filings, MLAB recorded 2 open-market insider purchases and 1 open-market sale (codes P and S; grants and option exercises excluded). 2 distinct insiders bought within the last 30 days. These are attributed public records — information, not instruction.
Is this page telling me to buy or sell MLAB?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerAnalyst Accuracy trackerThe platform

This is the teaser.

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.